
Growth Factor
CJC-1295 (no DAC)
Modified GRF (1-29), tetrasubstituted GRF(1-29)
Prices in AUD per vial. Check the selected option; product imagery is illustrative.
- Selected vial size
- 10mg
- Price per vial
- $79.00 AUD
- Payment
- PayID or bank transfer
Free Australian delivery over $250 before discounts; otherwise $12. Express Post dispatch within 1 business day of cleared payment; most metro addresses 1–2 business days after dispatch. Larger sizes are enquiry-only.
CJC-1295 without DAC is a modified GRF(1-29) sequence frequently paired with GHRPs in in-vitro secretagogue research. Supplied strictly for in-vitro laboratory research use.
CJC-1295 (no DAC) specifications
- Other names
- Modified GRF (1-29), tetrasubstituted GRF(1-29)
- Sequence
- Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Length
- 29 amino acids (C-terminal amide)
- Molecular formula
- C152H252N44O42
- Molecular weight
- 3367.9 g/mol
- CAS No.
- 863288-34-0
- Form
- Lyophilized Powder
- Vial size
- 10mg
Sequence, formula and molecular weight are compound reference data, not batch test results.
CJC-1295 (no DAC) price in Australia
$79.00 per 10mg lyophilised powder vial · $7.90 per mg
- 10% off automatically on orders of $300 or more
- 5% off your first order when you join our email list at checkout
- Free Express Post on orders over $250
- Dispatched from Brisbane within one business day of payment
Buying CJC-1295 (no DAC) in Australia
- Where can I buy CJC-1295 (no DAC) in Australia?
- You can buy CJC-1295 (no DAC) 10mg online from Nautic Peptides, an Australian supplier based in Brisbane (Nautic Peptides Pty Ltd, ABN 60 702 527 679). All stock is held in Australia and every order is sent from Brisbane by tracked Express Post.
- Can I buy CJC-1295 (no DAC) online in Australia?
- Yes. CJC-1295 (no DAC) is for sale online at nauticpeptides.com. Add it to your cart, check out in a few steps and pay by PayID or bank transfer, and your order ships once payment is confirmed, typically within 1 business day.
- How much is CJC-1295 (no DAC) in Australia?
- CJC-1295 (no DAC) 10mg is $79.00 per vial ($7.90 per mg) at Nautic Peptides. Orders of $300 or more get 10% off automatically, and delivery is free on orders over $250. A larger 20mg size is available on request.
- Is CJC-1295 (no DAC) available in Australia?
- Yes. CJC-1295 (no DAC) 10mg is available now, in stock in Queensland and ready to dispatch.
- How fast will my CJC-1295 (no DAC) order arrive?
- Orders are dispatched within one business day of payment by tracked Express Post. Australia Post's typical Express Post timeframe between metro areas is 1–2 business days, and you'll receive tracking as soon as your order ships.
- How do I pay for CJC-1295 (no DAC)?
- Pay securely by PayID or direct bank transfer. PayID usually arrives within minutes, and your order ships as soon as payment clears.
Often viewed with CJC-1295 (no DAC)
Batch documentation
Batch documentation for this product is being prepared. See our batch documentation page for published certificates, or contact us to request documentation.
For in-vitro laboratory research only. Not for human or veterinary use.
In the research literature
CJC-1295 without DAC, also called Modified GRF(1-29), is a 29-amino-acid analogue of the active 1-29 region of growth-hormone-releasing hormone (GHRH): Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2. Four substitutions (D-Ala2, Gln8, Ala15, Leu27) reduce enzymatic breakdown, including cleavage by dipeptidyl peptidase-4. In the literature, the name CJC-1295 refers to a different molecule: the same backbone with a lysine-maleimide Drug Affinity Complex (DAC) that binds serum albumin. In the 2005 study that identified CJC-1295, albumin conjugates of the modified sequence resisted dipeptidyl peptidase-4 in vitro and were active in a growth-hormone secretion assay using cultured rat anterior pituitary cells. A 2006 Phase 1 trial of the DAC version reported GH increases lasting six days or more and an estimated half-life of 5.8 to 8.1 days. Those results do not transfer to the non-DAC peptide, and no completed Phase 2 or 3 trials exist for it.
- Jetté et al., Endocrinology (2005) — hGRF(1-29)-albumin bioconjugates and identification of CJC-1295
- Teichman et al., J Clin Endocrinol Metab (2006) — Phase 1 trial of CJC-1295 (DAC version)
Cited studies describe published research findings, primarily from preclinical or early-phase models. This is not a claim of safety or effectiveness for human use.
CJC-1295 (no DAC) research and related reading
Often researched alongside: Ipamorelin 10mg